Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma
Yonsei Medical Journal
;
: 196-198, 2011.
Artículo
en Inglés
| WPRIM
| ID: wpr-136362
ABSTRACT
Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here we describe a patient with dyspnea and general weakness because of complete atrioventricular block while receiving bortezomib. We immediately stopped bortezomib, and after inserting a permanent VDD pacemaker, the patients' symptoms disappeared.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pirazinas
/
Ácidos Borónicos
/
Bloqueo Atrioventricular
/
Mieloma Múltiple
Límite:
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Yonsei Medical Journal
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS